drugset / Trial / NCT01506635

Effect of Timolol on Refractive Outcomes in Eyes With Myopic Regression After LASIK: a Randomized Clinical Trial

NCT01506635 ↗

RandomizedParallel-groupQuadruple-blindTreatment

Summary

In this randomized controlled clinical trial, we compare the effects of timolol versus placebo for treatment of myopic regression after LASIK

Timeline

Start
2010-03
Primary completion
2010-12
Completion
2010-12

Outcome

Met primary endpoint

paper SE was significantly better in Group 1 6 months after treatment and 6 months after discontinuation of treatment (P < .001 for both comparisons). PMID 22935601 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Timolol Other / unclassified 0.5 % Other

Indications